Viewing Study NCT05472467


Ignite Creation Date: 2025-12-25 @ 12:39 AM
Ignite Modification Date: 2026-03-01 @ 9:45 AM
Study NCT ID: NCT05472467
Status: UNKNOWN
Last Update Posted: 2022-07-25
First Post: 2022-07-21
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Camrelizumab Combination With SBRT and Concurrent Chemotherapy Treated Stage IV Oligometastatic Non-small Cell Lung Cancer
Sponsor:
Organization: